is a 5-HT3 antagonist used in the prevention and treatment ofchemotherapy induced nausea and vomiting (CINV). It is used for the control of delayed CINV—nausea and vomiting and there is tentative data that it may be better than granisetron.
Dosage: administered intravenously, as a single dose, 30 minutes before chemotherapy, for prevention of acute CINV .
Tropisterone has the same properties as Ondansetron above.
Capsule
392 EGP
is a 5-HT3 antagonist used in the prevention and treatment ofchemotherapy induced nausea and vomiting (CINV). It is used for the control of delayed CINV—nausea and vomiting and there is tentative data that it may be better than granisetron.
Dosage: administered intravenously, as a single dose, 30 minutes before chemotherapy, for prevention of acute CINV .
Tropisterone has the same properties as Ondansetron above.
Note: All the provided information about this drug does not substitute for consulting a doctor.